Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 3
2000 4
2001 3
2002 4
2003 2
2004 1
2005 2
2006 5
2008 3
2009 1
2010 1
2011 2
2012 5
2013 7
2014 2
2015 3
2016 6
2017 6
2018 5
2019 3
2020 3
2021 5
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Advances in antibody-based therapy in oncology.
Zinn S, Vazquez-Lombardi R, Zimmermann C, Sapra P, Jermutus L, Christ D. Zinn S, et al. Among authors: jermutus l. Nat Cancer. 2023 Feb;4(2):165-180. doi: 10.1038/s43018-023-00516-z. Epub 2023 Feb 20. Nat Cancer. 2023. PMID: 36806801 Review.
Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis.
Boland ML, Laker RC, Mather K, Nawrocki A, Oldham S, Boland BB, Lewis H, Conway J, Naylor J, Guionaud S, Feigh M, Veidal SS, Lantier L, McGuinness OP, Grimsby J, Rondinone CM, Jermutus L, Larsen MR, Trevaskis JL, Rhodes CJ. Boland ML, et al. Among authors: jermutus l. Nat Metab. 2020 May;2(5):413-431. doi: 10.1038/s42255-020-0209-6. Epub 2020 May 21. Nat Metab. 2020. PMID: 32478287 Free PMC article.
Exploiting protease activation for therapy.
Bleuez C, Koch WF, Urbach C, Hollfelder F, Jermutus L. Bleuez C, et al. Among authors: jermutus l. Drug Discov Today. 2022 Jun;27(6):1743-1754. doi: 10.1016/j.drudis.2022.03.011. Epub 2022 Mar 18. Drug Discov Today. 2022. PMID: 35314338 Free PMC article. Review.
Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes.
Parker VER, Robertson D, Erazo-Tapia E, Havekes B, Phielix E, de Ligt M, Roumans KHM, Mevenkamp J, Sjoberg F, Schrauwen-Hinderling VB, Johansson E, Chang YT, Esterline R, Smith K, Wilkinson DJ, Hansen L, Johansson L, Ambery P, Jermutus L, Schrauwen P. Parker VER, et al. Among authors: jermutus l. Nat Metab. 2023 Dec;5(12):2086-2093. doi: 10.1038/s42255-023-00938-0. Epub 2023 Dec 8. Nat Metab. 2023. PMID: 38066113 Free PMC article. Clinical Trial.
The role of pro-domains in human growth factors and cytokines.
Ratcliff M, Zhou RX, Jermutus L, Hyvönen M. Ratcliff M, et al. Among authors: jermutus l. Biochem Soc Trans. 2021 Nov 1;49(5):1963-1973. doi: 10.1042/BST20200663. Biochem Soc Trans. 2021. PMID: 34495310 Free PMC article. Review.
Challenges and opportunities for non-antibody scaffold drugs.
Vazquez-Lombardi R, Phan TG, Zimmermann C, Lowe D, Jermutus L, Christ D. Vazquez-Lombardi R, et al. Among authors: jermutus l. Drug Discov Today. 2015 Oct;20(10):1271-83. doi: 10.1016/j.drudis.2015.09.004. Epub 2015 Sep 7. Drug Discov Today. 2015. PMID: 26360055 Free article. Review.
In vitro selection and evolution of proteins.
Plückthun A, Schaffitzel C, Hanes J, Jermutus L. Plückthun A, et al. Among authors: jermutus l. Adv Protein Chem. 2000;55:367-403. doi: 10.1016/s0065-3233(01)55009-3. Adv Protein Chem. 2000. PMID: 11050939 Review. No abstract available.
Aggregation, stability, and formulation of human antibody therapeutics.
Lowe D, Dudgeon K, Rouet R, Schofield P, Jermutus L, Christ D. Lowe D, et al. Among authors: jermutus l. Adv Protein Chem Struct Biol. 2011;84:41-61. doi: 10.1016/B978-0-12-386483-3.00004-5. Adv Protein Chem Struct Biol. 2011. PMID: 21846562 Review.
Efficacy and safety of cotadutide, a dual glucagon-like peptide-1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease.
Parker VER, Hoang T, Schlichthaar H, Gibb FW, Wenzel B, Posch MG, Rose L, Chang YT, Petrone M, Hansen L, Ambery P, Jermutus L, Heerspink HJL, McCrimmon RJ. Parker VER, et al. Among authors: jermutus l. Diabetes Obes Metab. 2022 Jul;24(7):1360-1369. doi: 10.1111/dom.14712. Epub 2022 Apr 25. Diabetes Obes Metab. 2022. PMID: 35403793 Free PMC article. Clinical Trial.
80 results